作者:Wen-Yao Kong、Xiao-Feng Chen、Jing Shi、Shahla Karim Baloch、Jin-Liang Qi、Hai-Liang Zhu、Xiao-Ming Wang、Yong-Hua Yang
DOI:10.1002/chir.22209
日期:2013.11
selectively acylated by various fluorinated carboxylic acids at the side chain of shikonin, were synthesized and their anticancer activity evaluated, in which eight compounds are reported for the first time. Among all the compounds tested, compound S7 showed the most potent anticancer activity against B16‐F10 (malignant melanoma cells), MG63 (human osteosarcoma cells), and A549 (lung cancer cells) with
合成了一系列在紫草素侧链上被各种氟化羧酸选择性酰化的紫草素衍生物,并对其抗癌活性进行了评估,其中首次报道了八种化合物。在所有测试的化合物中,化合物S7对B16-F10(恶性黑色素瘤细胞),MG63(人骨肉瘤细胞)和A549(肺癌细胞)显示出最有效的抗癌活性,IC 50为0.39±0.01、0.72±0.04和0.58 ±0.02 µmol / L。进行化合物S7的对接模拟以将S7定位在微管蛋白活性位点,以确定可能的结合构象。所有结果表明,化合物S7可能是潜在的抗癌药。手性25:757–762,2013。©2013 Wiley Periodicals,Inc.